Supporting the healthy future of people around the world with biotechnology
Products
Veterinary Vaccines
Meiji Animal Health Co., Ltd.
KM Biologics has transferred its animal health business to its subsidiary, Meiji Animal Health Co., Ltd.
KM Biologics has transferred its animal health business to its subsidiary, Meiji Animal Health Co., Ltd.
Contact us to unfold a world of possibilities
NEWS
- Apr. 21, 2023
- Our disease awareness campaign for World Hemophilia Day
- Mar. 25, 2021
- KM Biologics Announces Phase I Clinical Study Results of a Live Attenuated Tetravalent Dengue Vaccine (KD-382)
- Dec. 21, 2018
- Nature, November special issue — KM Biologics: Safeguarding public health
- Oct. 31, 2018
- KM Biologics launches new website
Meiji Holdings
KM Biologics is a member of the Meiji Group. Learn more about Meiji Holdings.
